Update: Haemonetics Shares Rise After Fiscal Q2 Results Top Expectations

MT Newswires Live

Nov 07, 2025

(Updates to include Haemonetics' recent stock movement in the headline and first paragraph.)

Haemonetics (HAE) shares were up more than 28% in recent Thursday trading after the company posted fiscal Q2 results that topped expectations.

The company reported adjusted earnings of $1.27 per diluted share, compared with $1.12 a year earlier.

Two analysts surveyed by FactSet expected $0.99.

Revenue for the quarter ended Sept. 27 was $327.3 million, compared with $345.5 million a year earlier.

Analysts surveyed by FactSet expected $311.5 million.

The company raised the lower end of its 2026 adjusted EPS guidance to $4.80 to $5.00, up from $4.70 to $5.00 previously.

Price: 64.36, Change: +13.64, Percent Change: +26.89

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2581016266"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581016266\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581016266?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 00:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581016266","market":"nz","top_or_hot":-1,"title":"Update: Haemonetics Shares Rise After Fiscal Q2 Results Top Expectations","media":"MT Newswires Live","content":"<html><body><p> (Updates to include Haemonetics' recent stock movement in the headline and first paragraph.)</p><p>Haemonetics (HAE) shares were up more than 28% in recent Thursday trading after the company posted fiscal Q2 results that topped expectations.</p><p>The company reported adjusted earnings of $1.27 per diluted share, compared with $1.12 a year earlier.</p><p>Two analysts surveyed by FactSet expected $0.99.</p><p>Revenue for the quarter ended Sept. 27 was $327.3 million, compared with $345.5 million a year earlier.</p><p>Analysts surveyed by FactSet expected $311.5 million.</p><p>The company raised the lower end of its 2026 adjusted EPS guidance to $4.80 to $5.00, up from $4.70 to $5.00 previously.</p><p>Price: 64.36, Change: +13.64, Percent Change: +26.89</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Update: Haemonetics Shares Rise After Fiscal Q2 Results Top Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpdate: Haemonetics Shares Rise After Fiscal Q2 Results Top Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-11-07 00:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> (Updates to include Haemonetics' recent stock movement in the headline and first paragraph.)</p><p>Haemonetics (HAE) shares were up more than 28% in recent Thursday trading after the company posted fiscal Q2 results that topped expectations.</p><p>The company reported adjusted earnings of $1.27 per diluted share, compared with $1.12 a year earlier.</p><p>Two analysts surveyed by FactSet expected $0.99.</p><p>Revenue for the quarter ended Sept. 27 was $327.3 million, compared with $345.5 million a year earlier.</p><p>Analysts surveyed by FactSet expected $311.5 million.</p><p>The company raised the lower end of its 2026 adjusted EPS guidance to $4.80 to $5.00, up from $4.70 to $5.00 previously.</p><p>Price: 64.36, Change: +13.64, Percent Change: +26.89</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0012050646.USD","symbol_name":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2581016266","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581016266","pubTimestamp":1762447194,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Haemonetics  shares were up more than 28% in recent Thursday trading after the company posted fiscal Q2 results that topped expectations.The company reported adjusted earnings of $1.27 per diluted share, compared with $1.12 a year earlier.Two analysts surveyed by FactSet expected $0.99.Revenue for the quarter ended Sept. 27 was $327.3 million, compared with $345.5 million a year earlier.Analysts surveyed by FactSet expected $311.5 million.The company raised the lower end of its 2026 adjusted EPS guidance to $4.80 to $5.00, up from $4.70 to $5.00 previously.Price: 64.36, Change: +13.64, Percent Change: +26.89","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0012050646.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV","HAE":"美国血液技术","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","BK4198":"医疗保健用品","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","IE00B19Z6F94.USD":"Legg Mason Royce - US Smaller Companies A Acc USD","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","IE0034390439.USD":"FTGF ROYCE US SMALLER COMPANIES \"A\" (USD) D","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","LU0106261612.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC"},"translate_title":"更新：第二季度财报超出预期后Haemonetics股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HAE":1.5},"content_text":"(Updates to include Haemonetics' recent stock movement in the headline and first paragraph.)Haemonetics (HAE) shares were up more than 28% in recent Thursday trading after the company posted fiscal Q2 results that topped expectations.The company reported adjusted earnings of $1.27 per diluted share, compared with $1.12 a year earlier.Two analysts surveyed by FactSet expected $0.99.Revenue for the quarter ended Sept. 27 was $327.3 million, compared with $345.5 million a year earlier.Analysts surveyed by FactSet expected $311.5 million.The company raised the lower end of its 2026 adjusted EPS guidance to $4.80 to $5.00, up from $4.70 to $5.00 previously.Price: 64.36, Change: +13.64, Percent Change: +26.89","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}